Prostate cancer is the second most common cancer and the fifth leading cause of cancer-related deaths in men globally.
Radical prostatectomy (RP) is the primary treatment for localized prostate cancer but often leads to functional impairments, such as urinary incontinence (UI).
Membranous urethra length (MUL) may predict postoperative continence recovery, though study results are inconsistent.
